These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...

Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease Interventional procedure consultation Interventional procedures guidance 12 December 2024 Zilucoplan for treating ...

Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The guideline makes new recommendations and updates ...

Two technologies that could reduce the severity of the symptoms of chronic tic disorders and Tourette syndrome have been recommended for use in draft guidance from NICE. It is the first time a NICE ...

All NICE products on oesophageal cancer. Includes any guidance and quality standards.

Guidance that can help you make cost savings and find efficiencies in your local services. Includes impact reports and templates that allow you to accurately estimate savings for your local setting. A ...

Our processes and methods manual describes how we estimate the resource impact of NICE guidance. This ensures the assessments meet users' needs. The manual covers: NICE guidelines technology ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

Intermediate care services provide support for a short time to help you recover and increase your independence. This support is provided by a team of people who will work with you to achieve what you ...

According to the study, technologies that received scientific advice took a median of 312 days to progress from marketing authorisation to NICE guidance publication. In contrast, those without such ...